$25.16 0.39 (+1.57%)
12/3/2009 4:04 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating: 4 out of 5

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Recs

1
Member Avatar jvgarrison (66.42) Submitted: 6/14/2008 12:39:14 PM : Outperform Start Price: $18.55 BMY Score: +51.63

Another profitable company with a much above average dividend, and a potential takeover target due to its strong pipeline.

Report this Post 0 Comments

Featured Broker Partners